Alain Jordan is the founder of Aleva Neurotherapeutics. Aleva Neurotherapeutics has raised $8M in total funding. Latest round: Series E.
Alain Jordan is the CEO of Aleva Neurotherapeutics, a Swiss company founded in 2008 in Lausanne. The company specializes in developing advanced Deep Brain Stimulation (DBS) technologies, particularly for treating neurological disorders such as Parkinson's disease and essential tremor. Aleva Neurotherapeutics has raised a total of $8 million through various funding rounds, with the latest being a Series E round.
Full founder directory · Investor directory · Company funding database · Fundraising library